Abstract:Previous work in this laboratory has demonstrated that cerebral hypoperfusion increases the expression of prostaglandin endoperoxide synthase‐2 (PGHS‐2) in ovine fetal brain regions. Endogenously produced prostaglandins, in turn, partially mediate the fetal hypothalamus‐ pituitary‐adrenal (HPA) axis response to arterial hypotension. In separate experiments, we have found that oestradiol stimulates fetal HPA axis activity. The present experiments were designed to test the hypothesis that oestradiol increases the expression of PGHS isoforms, and that oestradiol augments the PGHS response to cerebral hypoperfusion. Sixteen fetal sheep of known gestational ages (124–128 days' gestation at the time of study) were subjected to chronic catheterization and implantation of extravascular occluder around the brachiocephalic artery. Eight fetuses were subjected to subcutaneous implantation of a pellet containing 17β‐oestradiol (release rate 5 mg (21 days)−1). Brachiocephalic occlusion (BCO) stimulated adrenocorticotropin (ACTH), cortisol and arginine vasopressin (AVP) secretion, responses that were augmented by oestradiol. One hour after the beginning of a 10 min period of BCO, PGHS‐1 mRNA was increased in fetal brainstem and hypothalamus, and PGHS‐2 mRNA was increased in fetal brainstem. Oestradiol, by itself, increased the abundance of PGHS‐2 mRNA in brainstem and cerebellum, and augmented the PGHS‐2 mRNA response to BCO in brainstem. In contrast, oestradiol had no significant effect on the abundance of PGHS‐1 mRNA in any brain region. PGHS‐1 and PGHS‐2 protein levels did not reflect the changes in the respective mRNAs. The abundance of both proteins was increased in cerebral cortex in response to BCO, and the abundance of PGHS‐2 protein was increased by both oestradiol and BCO in the hippocampus. The results of this study confirm and extend the results of our previous studies, demonstrating an effect of cerebral hypoperfusion on the expression of both isoforms of PGHS. We conclude that oestradiol increases the expression of PGHS‐2 in specific fetal brain regions, and that there is an interaction between oestradiol and BCO in the control of PGHS‐2 expression in the fetal brainstem. We expect that at later time‐points, the changes in mRNA would be followed by similar changes in enzyme abundance at the protein level. We speculate that at least a part of the effect of oestradiol on fetal HPA axis function is mediated by an interaction between oestradiol and prostaglandin biosynthesis in the fetal brain.

An Efficient Multi-Path to Active Peroxymonosulfate by Carbon and Sulfur Co-Doped Boron Nitride for Antibiotics Degradation: an Emerging Electron-Transfer Pathway at Activated-S Sites

Stable Incorporation of MnOx Quantum Dots into N-doped Hollow Carbon: A Synergistic Peroxymonosulfate Activator for Enhanced Removal of Bisphenol A

Photothermal nano-confinement reactor with bimetallic sites for enhanced peroxymonosulfate activation in antibiotic degradation

The surface asymmetric site regulation of carbon nitride oxide enabling peroxymonosulfate activation for degrading tetracycline

Mediated Peroxymonosulfate Activation at the Single Atom Fe-N3O1 Sites: Synergistic Degradation of Antibiotics by Two Non-Radical Pathways

Synchronously enhanced dual oxidation pathways via engineered Co-Nx/Co3O4 for high-efficiency degradation of versatile antibiotics

Enhanced PMS activation by Mn 2 O 3 -loaded h-BN for levofloxacin removal: Unveiling the dominant influence of non-free radical pathway and N-Mn-mediated promotion of stable, long-lived Mn(IV) species

Constructing an orderly electron transport channel on boron regulated biomass carbon fiber for selective ROS generation and water decontamination

Application of 3D hierarchical porous NiCo-spinel nanosheet array for enhancement of synergistic activation of peroxymonosulfate: Degradation, Intermediates, mechanism and degradation pathway of tetracycline

Multiple path-dominated activation of peroxymonosulfate by MOF-derived Fe2O3/Mn3O4 for catalytic degradation of tetracycline

Porous 3D superstructure of nitrogen doped carbon decorated with ultrafine cobalt nanodots as peroxymonosulfate activator for the degradation of sulfonamides

On the second eigenvalue of a graph

Fe3+/Fe2+ cycle promoted peroxymonosulfate activation with addition of boron for sulfamethazine degradation: Efficiency and the role of boron

ZIF-8 derived boron, nitrogen co-doped porous carbon as metal-free peroxymonosulfate activator for tetracycline hydrochloride degradation: Performance, mechanism and biotoxicity

Unveiling different antibiotic degradation mechanisms on dual reaction center catalysts with nitrogen vacancies via peroxymonosulfate activation

Roles of BOCu sites and graphite nitrogen on persulfate non-radical activation for tetracycline degradation

Effective removal of antibiotics from water by Cu2O/Co3O4-catalyzed peroxymonosulfate oxidation: catalytic performance and degradation mechanism

High Efficient PMS Activation by Synergistic Effects of Bimetallic Sulfide FeS2@MoS2 for Rapid OFX Degradation

Enhanced Peroxymonosulfate activation via Bi 12 CoO 20 /rGO with Near‐Infrared Photothermal Response for Antibiotics Degradation

MOF derived highly dispersed bimetallic Fe-Ni nitrogen-doped carbon for enhanced peroxymonosulfate activation and tetracycline degradation

Central Nervous System Prostaglandin Endoperoxide Synthase‐1 and −2 Responses to Oestradiol and Cerebral Hypoperfusion in Late‐Gestation Fetal Sheep